Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5087551
Max Phase: Preclinical
Molecular Formula: C16H27NO23S3
Molecular Weight: 697.58
Molecule Type: Unknown
Associated Items:
ID: ALA5087551
Max Phase: Preclinical
Molecular Formula: C16H27NO23S3
Molecular Weight: 697.58
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCOCCO[C@@H]1O[C@@H](C(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](OS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1OS(=O)(=O)O
Standard InChI: InChI=1S/C16H27NO23S3/c17-1-2-33-3-4-34-15-9(39-42(27,28)29)5(18)7(11(36-15)13(20)21)35-16-10(40-43(30,31)32)6(19)8(38-41(24,25)26)12(37-16)14(22)23/h5-12,15-16,18-19H,1-4,17H2,(H,20,21)(H,22,23)(H,24,25,26)(H,27,28,29)(H,30,31,32)/t5-,6-,7-,8-,9+,10+,11+,12+,15+,16+/m0/s1
Standard InChI Key: QBBUOMVOFHKUNL-SCONTCDCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 697.58 | Molecular Weight (Monoisotopic): 697.0136 | AlogP: -5.73 | #Rotatable Bonds: 16 |
Polar Surface Area: 378.03 | Molecular Species: ZWITTERION | HBA: 19 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -2.70 | CX Basic pKa: 9.45 | CX LogP: -8.76 | CX LogD: -17.00 |
Aromatic Rings: 0 | Heavy Atoms: 43 | QED Weighted: 0.05 | Np Likeness Score: 0.88 |
1. Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R.. (2021) Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development., 64 (6.0): [PMID:33683903] [10.1021/acs.jmedchem.0c01800] |
Source(1):